Hollister Incorporated, Current Statement Related to COVID-19 Pandemic

Dear Valued Customers and Partners, we remain here for you.

The day-to-day situation and needs associated with the spread of COVID-19 continues to evolve and bring unique and individual challenges for all of us. We share in your many concerns and we are determined to be here for you and available to assist with your product questions and needs.

These are the facts that we know are important for you to hear from us:

•  At this time, we are fully operational, and we do not anticipate the pandemic to have any impact on our ability to supply our ostomy or continence care products to current customers or others in need.
•  Our customer service teams are enabled to work from home so they can shelter in place while continuing to be available to respond to your product questions and needs.
•  Our manufacturing facilities located in Denmark, India, Ireland, Lithuania, and the United States continue to work diligently to meet ongoing supply needs. We have instituted many US and European Centers for Disease Control and Prevention recommendations, and local government guidelines, to help keep our Associates out of harm’s way while they continue to work in our facilities.

“Our company mission, focused on serving others, is all the more critical in times of crisis,” said V. George Maliekel, Hollister Incorporated President and CEO. “Our priorities during this global pandemic are twofold; first, to take care of ourselves, our loved ones, and each other, so in turn, we can take care of our customers who rely on us every day.”

We continue to monitor the COVID-19 situation closely and will share new developments as appropriate.

If you have any questions or concerns, please contact your local Customer Service Team at 1.800.880.851 or email us at priority@libmed.com.au or corporate.communications@hollister.com.